Cardio-renal-metabolic overlap, outcomes, and treatment with dapagliflozin in heart failure with mildly reduced or preserved ejection fraction

20 May 2023 (14:00 - 14:45)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor John Ostrominski

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

7 More presentations in this session

Presentation thumbnail

Impact of anemia on long-term clinical outcome in patients with mildly reduced left ventricular systolic function after acute myocardial infarction

Doctor J. Seung (Seoul, KR)

Abstract Slides

Presentation thumbnail

Cardio-renal-metabolic syndrome in a cohort of patients with chronic heart failure: prevalence and prognosis. An analysis of OFFICE IC AR Registry

Doctor J. Thierer (Buenos Aires, AR)

Abstract Slides

Presentation thumbnail

The patter of muscle mass wasting in elder patients with heart failure is associated with mortality: a post-hoc analysis of the FRAGILE-HF

Mr T. Sunayama (Tokyo, JP)

Abstract Slides

Presentation thumbnail

Soluble transferrin receptor as a marker of tissue iron deficiency: impact on cardiac, systemic, hematinic and neurohormonal biomarkers in patients with heart failure without systemic iron deficiency

Doctor R. Ramos Polo (Hospitalet De Llobregat, ES)

Abstract Slides

Presentation thumbnail

REVEAL-CKD: Prevalence of undiagnosed stage 3 chronic kidney disease in patients with heart failure in Canada

Doctor K. Jarbrink (Gothenburg, SE)

Abstract Slides

Access the full session

Session thumbnail

Chronic heart failure - comorbidities

The Event

Event poster

Heart Failure 2023

20 May 2023 14:00 CET

You may be interested in

Congress Session

Chronic kidney disease and heart failure

Congress Presentation

Spectrum of non-cardiac comorbidities

Congress Presentation

Clinical characteristics of newly diagnosed vs. chronic heart failure patients in Spain: SEC-Excelente registry results.